RELATED: CVS Caremark grows platform for PBM clients to manage digital health tools IVP is a later-stage partner for companies such as Coinbase, Lyra Health, Slack, Snap, Twitter and UiPath. Hello Heart has an opportunity to become the digital therapeutics leader for all cardiovascular diseases and we’re excited to partner with them on their growth phase,” said Somesh Dash, general partner at IVP and now a member of Hello Heart’s board of directors. “The market for heart disease is large and adoption of digital solutions is accelerating quickly. These clinical results are more than two times higher than any other results ever documented and published in a peer-reviewed clinical study, according to the company. That was critical for continuity of care,” Cohen said.Īccording to a recent peer-reviewed study performed by researchers from the University of California, Los Angeles and Harvard Medical School, 70% of Hello Heart users reduced their blood pressure, and the average decrease of systolic blood pressure was 22 mmHg. “Hello Heart is essential during the pandemic since members are able to share accurate BP readings with any clinician they work with from home-their PCP, cardiologist or telehealth urgent care doctor. Hello Heart’s healthcare technology became even more critical during COVID-19, company executives say. The program has also been added to CVS Health’s Point Solutions Management platform. In the past year, Hello Heart's business has tripled, with some programs now being offered as part of employee benefit plans. Knowing when you need to reach out to get help can save lives.” “Many of our users were able to be notified in time that they might be at risk, allowing them to call 911 directly from the app or share the numbers with their doctor for an immediate diagnosis. “Users were incredibly thankful for the hypertension crisis flow and irregular heartbeat alerts that we added this year,” Hello Heart’s CEO Maayan Cohen told Fierce Healthcare. RELATED: Mayo Clinic launches 2 new companies to use patient data and AI to advance early disease detection The idea behind the technology is that a user can get personalized healthcare suggestions without having to talk to a live person. Tools include a digital blood pressure cuff that connects to an app, which tracks readings, weight and physical activity and offers medication reminders. In addition, the company's AI technology can detect more serious cardiac events such as irregular heartbeat or a hypertensive crisis. Users can track their health information from a smartphone and then receive feedback and suggestions of health improvements via the phone. Launched in 2013, the digital therapeutic company's app helps patients manage their blood pressure, pulse, medications and physical activity using artificial intelligence. Hello Heart plans to use the fresh capital to continue growing the team and expanding the product offering to additional clinical heart health offerings.
0 kommentar(er)
